Last $107.71 USD
Change Today 0.00 / 0.00%
Volume 8.1K
PCRX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 9:36 AM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James S. Scibetta

Chief Financial Officer, Senior Vice President and Secretary, Pacira Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 board members in 1 different organizations across 5 different industries.

See Board Relationships
49$469,030
As of Fiscal Year 2013

Background*

Mr. James S. Scibetta, also known as Jim, has been the Chief Financial Officer for Pacira Pharmaceuticals, Inc. since August 2008 and has been its Senior Vice President since 2014. Mr. Scibetta serves as Secretary of Pacira Pharmaceuticals, Inc. Mr. Scibetta has 13 years of experience in investment banking having worked on Wall Street. He served as the Chief Financial Officer of Bioenvision Inc., since December 1, 2006 and also served as its Principal Accounting Officer. ...

Read Full Background

Corporate Headquarters*

5 Sylvan Way
Parsippany, New Jersey 07054

United States

Phone: 973-254-3560
Fax: --

Board Members Memberships*

2001-2008
Former Director and Chairman of Audit Committee
2007-2013
Former Chairman of the Board and Chairman of Audit Committee
2013-Present
Director

Education*

MBA
University of Michigan
BS
Wake Forest University

Other Affiliations*

Annual Compensation*

Salary$328,400
Bonus$140,000
Total Annual Compensation$468,400

Stock Options*

All Other Compensation$630
Exercised Options40,000
Exercised Options Value$1,523,826
Exercisable Options189,596
Exercisable Options Value$9,923,251
Unexercisable Options120,655
Unexercisable Options Value$5,828,408
Total Value of Options$17,275,485
Total Number of Options350,251

Total Compensation*

Total Annual Cash Compensation$469,030
Total Short Term Compensation$468,400
Other Long Term Compensation$630
Total Calculated Compensation$469,030
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PCRX:US $107.71 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
Kevin A. Lobo Chairman and Chief Executive Officer
Stryker Corporation
$1.0M
Benson F. Smith Chairman, Chief Executive Officer, President and Member of Non-Executive Equity Awards Committee
Teleflex Incorporated
$826.6K
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
$620.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PACIRA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.